Silverarc Capital Management’s Mineralys Therapeutics MLYS Stock Holding History

Silverarc Capital Management’s Portfolio MLYS Stock Details MLYS Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell
2025 Q4	$3.45M	Buy
2025 Q3	$3.03M	Sell
2025 Q2	$1.56M	Sell
2025 Q1	$5.37M	Buy
2024 Q2	–	Sell
2024 Q1	$735K	Buy